
Source briefing
Persistent Bartonella quintana Infection in Macaques at Primate Research Institute, Japan
Y. Nomura et al.
Read →
Source briefing
Variolation Techniques, Medical Explanations, and Dissemination in Late Imperial China
L. Guan et al.
Read →

Source briefing
Human medicines European public assessment report (EPAR): Vevzuo, denosumab, Date of authorisation: 25/06/2025, Revision: 4, Status: Authorised
Human medicines European public assessment report (EPAR): Vevzuo, denosumab, Date of authorisation: 25/06/2025, Revision: 4, Status: Authorised
Read →
Source briefing
Human medicines European public assessment report (EPAR): Fintepla, fenfluramine, Date of authorisation: 18/12/2020, Revision: 18, Status: Authorised
Human medicines European public assessment report (EPAR): Fintepla, fenfluramine, Date of authorisation: 18/12/2020, Revision: 18, Status: Authorised
Read →
Source briefing
Human medicines European public assessment report (EPAR): Grasustek, pegfilgrastim, Date of authorisation: 20/06/2019, Revision: 9, Status: Authorised
Human medicines European public assessment report (EPAR): Grasustek, pegfilgrastim, Date of authorisation: 20/06/2019, Revision: 9, Status: Authorised
Read →
Source briefing
The retail food environment following a mandatory healthy checkout policy: A natural experimental evaluation
by Yuru Huang, Ethan C. Wolf, Andrea M. Gil, Kris Jayme G. Matas, Lisa M. Powell, Rebecca M. Schermbeck, Jennifer Falbe Background In January 2024, Perris, California, became the third jurisdiction worldwide to implement a mandatory healthy checkout…
Read →
Source briefing
Clinical Characterization of Invasive Meningococcal Disease Epidemic, Uzbekistan, 2026
B. B. Rakhimov et al.
Read →
Source briefing
ICH E14/S7B (R1) Q&As: The clinical evaluation of QT/ QTc interval prolongation and proarrhythmic potential for non-antiarrhythmic drugs – Questions and Answers
ICH E14/S7B (R1) Q&As: The clinical evaluation of QT/ QTc interval prolongation and proarrhythmic potential for non-antiarrhythmic drugs - Questions and Answers
Read →
Source briefing
Human medicines European public assessment report (EPAR): Mepact, mifamurtide, Date of authorisation: 06/03/2009, Revision: 23, Status: Authorised
Human medicines European public assessment report (EPAR): Mepact, mifamurtide, Date of authorisation: 06/03/2009, Revision: 23, Status: Authorised
Read →